Primary malignant intestinal lymphoma.
BACKGROUND
Primary malignant intestinal lymphoma is an uncommon gut malignancy. Its incidence has been increasing over the past century. We in this study attempt to define its clinico-pathological profile and to share our experience with multidisciplinary approach to management.


METHODS
Our experience of seven patients with a diagnosis of primary intestinal lymphoma over a period of 22 months is presented here. All the cases were followed up prospectively over a period varying from 8 months to 20 months.


CONCLUSIONS
Of the 7 patients 4 were males and 3 females (mean age 56.3 years). Acute intestinal obstruction was the commonest presentation. Imaging modalities revealed abnormality in all the cases but were rarely diagnostic. Most patients presented at an early stage when the disease was confined to the bowel. The commonest site was the large intestine (42.6%) especially the caecum. Diffuse large cell, high grade tumour were found to be the commonest histological type. Surgery followed by adjuvant chemotherapy gave good results.
Babu
R D
RD
Department of Surgery, Medical College Kottayam, Kottayam, Kerala-686 006, India.
Damodaran
D
D
D000328:Adult; D000368:Aged; D000970:Antineoplastic Agents / Q000627:therapeutic use; D001466:Barium Sulfate; D003082:Colectomy / Q000379:methods; D003131:Combined Modality Therapy; D016099:Endoscopy, Gastrointestinal; D004733:Enema; D005260:Female; D006801:Humans; D007089:Image Enhancement / Q000379:methods; D007414:Intestinal Neoplasms / Q000175:diagnosis* / Q000628:therapy; D008228:Lymphoma, Non-Hodgkin / Q000175:diagnosis* / Q000628:therapy; D008297:Male; D008875:Middle Aged; D009367:Neoplasm Staging; D011379:Prognosis; D012189:Retrospective Studies; D014057:Tomography, X-Ray Computed; D016896:Treatment Outcome
D000970:Antineoplastic Agents; D001466:Barium Sulfate